ES2061509T3 - Composicion de interferon leucocitario humano y tratamiento de la piel. - Google Patents

Composicion de interferon leucocitario humano y tratamiento de la piel.

Info

Publication number
ES2061509T3
ES2061509T3 ES87308861T ES87308861T ES2061509T3 ES 2061509 T3 ES2061509 T3 ES 2061509T3 ES 87308861 T ES87308861 T ES 87308861T ES 87308861 T ES87308861 T ES 87308861T ES 2061509 T3 ES2061509 T3 ES 2061509T3
Authority
ES
Spain
Prior art keywords
composition
interferon
human
treatment
leukocytary
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES87308861T
Other languages
English (en)
Inventor
David C Munch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viragen Inc
Original Assignee
Viragen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viragen Inc filed Critical Viragen Inc
Application granted granted Critical
Publication of ES2061509T3 publication Critical patent/ES2061509T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
    • A61K8/983—Blood, e.g. plasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/212—IFN-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

SE PRESENTA UNA COMPOSICION TOPICA QUE CONTIENE INTERFERON DE LEUCOCITOS HUMANOS PARA TRATAMIENTO DERMATOLOGICO. LA COMPOSICION INCLUYE INTERFERON Y UN PENETRANTE REFORZADOR DISPERSADO ENUN VEHICULO INERTE Y NO TOXICO, Y PUEDEN INCLUIR UN AGENTE SUAVIZANTE. LA COMPOSICION ESTA PARTICULARMENTE BIEN INDICADA PARA TRATAMIENTO DE LESIONES DE LA PIEL CAUSADAS POR HERPES SIMPLEX, VERRUGAS VENEREAS, CONDILOMA Y SIMILARES. EL TRATAMIENTO INCLUYE LA APLICACION DE LA COMPOSICION TOPICA DIRECTAMENTE A LAS ZONAS INFECTADAS.
ES87308861T 1986-11-10 1987-10-06 Composicion de interferon leucocitario humano y tratamiento de la piel. Expired - Lifetime ES2061509T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92845086A 1986-11-10 1986-11-10

Publications (1)

Publication Number Publication Date
ES2061509T3 true ES2061509T3 (es) 1994-12-16

Family

ID=25456251

Family Applications (1)

Application Number Title Priority Date Filing Date
ES87308861T Expired - Lifetime ES2061509T3 (es) 1986-11-10 1987-10-06 Composicion de interferon leucocitario humano y tratamiento de la piel.

Country Status (7)

Country Link
EP (1) EP0267684B1 (es)
JP (1) JP2681467B2 (es)
KR (1) KR960011231B1 (es)
CA (1) CA1321347C (es)
DE (1) DE3750248T2 (es)
ES (1) ES2061509T3 (es)
IL (1) IL84080A0 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3803312A1 (de) * 1988-02-04 1989-08-10 Gerd Prof Dr Med Gross Verwendung eines interferonenthaltenden gels
KR900701322A (ko) * 1988-07-05 1990-12-01 스타이너 브이. 캔스타트 포도필린과 재조합 DNA인간 α인터페론의 배합물로 생식기 우췌를 치료하는 방법
US4959210A (en) * 1988-11-01 1990-09-25 Schering Corporation Treatment of genital warts with a combination of liquid nitrogen and recombinant DNA human alpha interferon
US5723215A (en) * 1994-09-30 1998-03-03 E. I. Du Pont De Nemours And Company Bicomponent polyester fibers
US5882794A (en) * 1994-09-30 1999-03-16 E. I. Du Pont De Nemours And Company Synthetic fiber cross-section
RU2173155C1 (ru) * 2000-12-19 2001-09-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Ранозаживляющий, противовоспалительный и противоинфекционный лекарственный препарат

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3551554A (en) * 1968-08-16 1970-12-29 Crown Zellerbach Corp Enhancing tissue penetration of physiologically active agents with dmso
JPS5562024A (en) * 1978-10-31 1980-05-10 Hayashibara Takeshi Preventive and remedy for interferon-sensitive disease
WO1983001198A1 (en) * 1981-10-08 1983-04-14 Kurt Frimann Berg Method and composition for treating a patient suffering from interferon-susceptible disorder
CA1190148A (en) * 1981-10-13 1985-07-09 Samuel S. Asculai Interferon-containing compositions
EP0305551A3 (en) * 1981-10-13 1990-01-10 Exovir, Inc. Pharmaceutical compositions for topical application
US4435384A (en) * 1982-04-30 1984-03-06 Viragen, Inc. Transfer factor composition and skin treatment
US4605555A (en) * 1984-09-20 1986-08-12 Sun Star Kabushiki Kaisha Composition and method for treating keratosic disorder of skin and mucosa

Also Published As

Publication number Publication date
CA1321347C (en) 1993-08-17
KR960011231B1 (ko) 1996-08-21
KR880005920A (ko) 1988-07-21
EP0267684A3 (en) 1988-11-23
EP0267684B1 (en) 1994-07-20
IL84080A0 (en) 1988-03-31
JP2681467B2 (ja) 1997-11-26
DE3750248D1 (de) 1994-08-25
DE3750248T2 (de) 1995-03-16
JPS63130539A (ja) 1988-06-02
EP0267684A2 (en) 1988-05-18

Similar Documents

Publication Publication Date Title
AU8335291A (en) Drugs, their manufacture, and their use as painkillers and/or to treat inflammations in humans and animals
ES2046300T3 (es) Composicion para el tratamiento de la piel.
ES2087061T3 (es) Utilizacion de ribosido o ribotido de aica para la fabricacion de un medicamento contra la crisis cardiaca o el infarto de miocardio en los pacientes que sufren de ateroesclerosis.
EP0489108A4 (en) Method and composition for the treatment of cutaneous, ocular, and mucosal hypersensitivity, inflammation, and hyperproliferative conditions using topical preparations of serotonin antagonists
PE19496A1 (es) Formulacion de analogo de insulina humana
AU569431B2 (en) Pharmaceutical composition containing phenindamine
DE3881340D1 (de) Vorrichtung zur transdermalen applikation von medikamenten.
FI972642L (fi) Galeeninen yksikkökoostumus käytettäväksi paikallisesti hedelmöityksen ehkäisyyn ja/tai sukupuoliteitse välittyvien sairauksien ja/tai HIV:n vastaiseen taisteluun
DE3584766D1 (de) Transdermales system fuer timolol.
ES2057124T3 (es) Producto terapeutico para el tratamiento de estados peri- o post-menopausicos.
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
AU1865100A (en) Hyaluronate lyase used for promoting penetration in topical agents
ES2131122T3 (es) Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina.
AU5916990A (en) Preparations for topical use containing depolymerized deoxyribonucleic acids to reduce unsightly defects of the epidermis of the face and some skin areas of the body
ITRM970731A0 (it) Composizione per il trattamento di ustioni eritemi solari abrasioni piaghe e irritazioni cutanee
ES2061509T3 (es) Composicion de interferon leucocitario humano y tratamiento de la piel.
FR2598320B1 (fr) Compositions pharmaceutiques hydrosolubles contenant de l'ubiquinone en tant que principe actif, utiles dans differentes applications therapeutiques
DE69133077D1 (de) Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung
AU4739089A (en) Superficial therapeutic system comprising an anti-neoplastic active substance, particularly 5-fluorouracil
ES2052922T3 (es) Nucleosidos terapeuticos.
AU3401093A (en) Therapeutic agent for threatened abortion
ATE405276T1 (de) Pharmazeutische gel-zusammensetzung
AU4040195A (en) Topical composition containing penciclovir
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
ZA873928B (en) Topical methotrexate preparation for the treatment of hyperproliferative epithelial disease

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 267684

Country of ref document: ES